Industry: Service & Software
Published Date: 2026-07-16
Pages: 196 Pages
Report ld: 6977074
Request Sample
Customized Report
Proteomics Analytical Service Market Size(US$)

CAGR 2026-2032
10.4%
Market Size,2032
USD 6,602
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Proteomics Analytical Service market size was US$ 3392 million in 2025 and is forecast to reach a readjusted size of US$ 6602 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Proteomics Analytical Services refer to professional outsourced research solutions that utilize advanced proteomics technologies to provide protein identification, quantification, functional characterization, data interpretation, and biological mechanism discovery services for academic institutions, pharmaceutical companies, biotechnology companies, healthcare organizations, and research users.
These services typically include sample preparation, protein extraction, enzymatic digestion, liquid chromatography separation, high-resolution mass spectrometry analysis (LC-MS/MS), multiplex protein profiling, post-translational modification (PTM) analysis, protein interaction studies, single-cell proteomics, spatial proteomics, and bioinformatics interpretation.
Unlike traditional laboratory outsourcing, Proteomics Analytical Services integrate high-sensitivity analytical platforms, standardized workflows, large-scale protein databases, and advanced computational analysis capabilities to transform complex protein datasets into actionable biological insights. The service model has become a critical infrastructure for drug discovery, disease mechanism investigation, biomarker identification, precision medicine, immunotherapy development, and translational research. Driven by artificial intelligence, multi-omics integration, and high-throughput technologies, Proteomics Analytical Services are evolving from simple analytical outsourcing toward integrated solutions combining experimental design, technology platforms, data analytics, and scientific discovery.
The Proteomics Analytical Services industry primarily adopts a technology-driven CRO (Contract Research Organization) business model. Service providers establish advanced mass spectrometry platforms, multiplex protein analysis systems, automated sample preparation capabilities, and bioinformatics infrastructure to deliver customized research solutions. Typical workflows include project consultation, experimental design, sample quality control, analytical testing, data processing, statistical interpretation, biological validation, and final research reporting.
From an industry chain perspective, upstream suppliers include mass spectrometry manufacturers, liquid chromatography providers, laboratory consumable suppliers, biochemical reagent companies, antibody developers, protein standards suppliers, and computing infrastructure providers. The midstream sector consists of specialized proteomics CRO companies, multi-omics service platforms, and research technology providers. Downstream customers include pharmaceutical companies, biotechnology firms, hospitals, universities, government research organizations, and agricultural biotechnology companies. Large-scale CRO providers leverage global laboratory networks and standardized quality systems to support pharmaceutical customers from early discovery through translational research.
Proteomics Analytical Services generally achieve attractive profitability due to their high technical complexity and specialized capabilities. Advanced services such as clinical proteomics, drug target discovery, spatial proteomics, and single-cell proteomics typically generate gross margins of approximately 50%-70% due to high technical barriers, significant equipment investment, and specialized expertise requirements. Standardized protein analysis and routine mass spectrometry services usually achieve margins of around 30%-50% because of stronger competition. Companies with proprietary algorithms, biological databases, and differentiated analytical platforms can achieve margins above 60% through technology advantages and long-term customer relationships.
Proteomics Analytical Services are becoming a strategic growth area within the global life science research ecosystem. Increasing investment in innovative drug development is accelerating demand for efficient and accurate target discovery, biomarker identification, and mechanism-of-action studies. Proteomics provides functional molecular information that cannot be fully captured by genomics alone, creating significant value in oncology, immunology, neurological research, metabolic disease studies, and precision medicine. The integration of multi-omics technologies, artificial intelligence-driven data interpretation, and automated laboratory platforms will further improve research efficiency and commercial scalability.
The Proteomics Analytical Services industry faces challenges including high technological complexity, significant capital requirements, limited analytical standardization, and shortages of specialized scientific talent. Advanced mass spectrometry platforms and emerging protein analysis technologies require continuous investment in research infrastructure. In addition, demand fluctuations caused by biotechnology funding cycles, drug development timelines, and customer budget adjustments may create operational uncertainty. Companies must continuously strengthen technology platforms, quality systems, and computational capabilities to maintain competitive advantages.
Future demand for Proteomics Analytical Services will increasingly move toward high-throughput analysis, precision applications, clinical translation, and AI-enabled interpretation. Pharmaceutical and biotechnology companies will remain major customers by outsourcing proteomics studies to reduce R&D costs and accelerate drug development timelines. Hospitals and diagnostic companies will expand applications in early disease detection, biomarker validation, and companion diagnostics. Academic and research institutions will continue advancing single-cell proteomics, spatial proteomics, and multi-omics integration. As life science research becomes increasingly data-driven, proteomics service providers with advanced technology platforms, analytical capabilities, and global delivery networks will capture stronger market opportunities.
The global Proteomics Analytical Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Proteomics Analytical Service value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Standard Proteomics
1.2.3 Modified Proteomics
1.2.4 Spatial Proteomics
1.2.5 Blood Proteomics
1.2.6 Other Proteomics
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Clinical Diagnostics
1.3.3 Drug Discovery
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Proteomics Analytical Service Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Proteomics Analytical Service Market Share by Revenue, by Region (2021-2026)
2.4 Global Proteomics Analytical Service Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Proteomics Analytical Service Market Size and Prospective (2021-2032)
2.5.2 Europe Proteomics Analytical Service Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Proteomics Analytical Service Market Size and Prospective (2021-2032)
2.5.4 Latin America Proteomics Analytical Service Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Proteomics Analytical Service Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Proteomics Analytical Service Historical Market Size by Type (2021-2026)
3.2 Global Proteomics Analytical Service Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Proteomics Analytical Service
4 Breakdown Data by Application
4.1 Global Proteomics Analytical Service Historical Market Size by Application (2021-2026)
4.2 Global Proteomics Analytical Service Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Proteomics Analytical Service Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Proteomics Analytical Service Players by Revenue (2021-2026)
5.1.2 Global Proteomics Analytical Service Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Proteomics Analytical Service Revenue
5.4 Global Proteomics Analytical Service Market Concentration Analysis
5.4.1 Global Proteomics Analytical Service Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Proteomics Analytical Service Revenue in 2025
5.5 Global Key Players of Proteomics Analytical Service Head Offices and Areas Served
5.6 Global Key Players of Proteomics Analytical Service, Product and Application
5.7 Global Key Players of Proteomics Analytical Service, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Proteomics Analytical Service Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Proteomics Analytical Service Market Size by Type (2021-2026)
6.1.2.2 North America Proteomics Analytical Service Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Proteomics Analytical Service Market Size by Application (2021-2026)
6.1.3.2 North America Proteomics Analytical Service Market Share by Application (2021-2026)
6.1.4 North America Proteomics Analytical Service Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Proteomics Analytical Service Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Proteomics Analytical Service Market Size by Type (2021-2026)
6.2.2.2 Europe Proteomics Analytical Service Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Proteomics Analytical Service Market Size by Application (2021-2026)
6.2.3.2 Europe Proteomics Analytical Service Market Share by Application (2021-2026)
6.2.4 Europe Proteomics Analytical Service Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Proteomics Analytical Service Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Proteomics Analytical Service Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Proteomics Analytical Service Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Proteomics Analytical Service Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Proteomics Analytical Service Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Proteomics Analytical Service Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Proteomics Analytical Service Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Proteomics Analytical Service Market Size by Type (2021-2026)
6.4.2.2 Latin America Proteomics Analytical Service Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Proteomics Analytical Service Market Size by Application (2021-2026)
6.4.3.2 Latin America Proteomics Analytical Service Market Share by Application (2021-2026)
6.4.4 Latin America Proteomics Analytical Service Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Proteomics Analytical Service Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Proteomics Analytical Service Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Proteomics Analytical Service Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Proteomics Analytical Service Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Proteomics Analytical Service Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Proteomics Analytical Service Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Olink (Thermo Fisher Scientific)
7.1.1 Olink (Thermo Fisher Scientific) Company Details
7.1.2 Olink (Thermo Fisher Scientific) Business Overview
7.1.3 Olink (Thermo Fisher Scientific) Proteomics Analytical Service Introduction
7.1.4 Olink (Thermo Fisher Scientific) Revenue in Proteomics Analytical Service Business (2021-2026)
7.1.5 Olink (Thermo Fisher Scientific) Recent Development
7.2 SomaLogic (Illumina)
7.2.1 SomaLogic (Illumina) Company Details
7.2.2 SomaLogic (Illumina) Business Overview
7.2.3 SomaLogic (Illumina) Proteomics Analytical Service Introduction
7.2.4 SomaLogic (Illumina) Revenue in Proteomics Analytical Service Business (2021-2026)
7.2.5 SomaLogic (Illumina) Recent Development
7.3 CellCarta
7.3.1 CellCarta Company Details
7.3.2 CellCarta Business Overview
7.3.3 CellCarta Proteomics Analytical Service Introduction
7.3.4 CellCarta Revenue in Proteomics Analytical Service Business (2021-2026)
7.3.5 CellCarta Recent Development
7.4 PTM BIO
7.4.1 PTM BIO Company Details
7.4.2 PTM BIO Business Overview
7.4.3 PTM BIO Proteomics Analytical Service Introduction
7.4.4 PTM BIO Revenue in Proteomics Analytical Service Business (2021-2026)
7.4.5 PTM BIO Recent Development
7.5 Standard Biotools
7.5.1 Standard Biotools Company Details
7.5.2 Standard Biotools Business Overview
7.5.3 Standard Biotools Proteomics Analytical Service Introduction
7.5.4 Standard Biotools Revenue in Proteomics Analytical Service Business (2021-2026)
7.5.5 Standard Biotools Recent Development
7.6 Labcorp
7.6.1 Labcorp Company Details
7.6.2 Labcorp Business Overview
7.6.3 Labcorp Proteomics Analytical Service Introduction
7.6.4 Labcorp Revenue in Proteomics Analytical Service Business (2021-2026)
7.6.5 Labcorp Recent Development
7.7 BostonGene
7.7.1 BostonGene Company Details
7.7.2 BostonGene Business Overview
7.7.3 BostonGene Proteomics Analytical Service Introduction
7.7.4 BostonGene Revenue in Proteomics Analytical Service Business (2021-2026)
7.7.5 BostonGene Recent Development
7.8 APTBIO
7.8.1 APTBIO Company Details
7.8.2 APTBIO Business Overview
7.8.3 APTBIO Proteomics Analytical Service Introduction
7.8.4 APTBIO Revenue in Proteomics Analytical Service Business (2021-2026)
7.8.5 APTBIO Recent Development
7.9 Cell Signaling Technology (CST)
7.9.1 Cell Signaling Technology (CST) Company Details
7.9.2 Cell Signaling Technology (CST) Business Overview
7.9.3 Cell Signaling Technology (CST) Proteomics Analytical Service Introduction
7.9.4 Cell Signaling Technology (CST) Revenue in Proteomics Analytical Service Business (2021-2026)
7.9.5 Cell Signaling Technology (CST) Recent Development
7.10 Inotiv
7.10.1 Inotiv Company Details
7.10.2 Inotiv Business Overview
7.10.3 Inotiv Proteomics Analytical Service Introduction
7.10.4 Inotiv Revenue in Proteomics Analytical Service Business (2021-2026)
7.10.5 Inotiv Recent Development
7.11 Bruker Spatial Biology
7.11.1 Bruker Spatial Biology Company Details
7.11.2 Bruker Spatial Biology Business Overview
7.11.3 Bruker Spatial Biology Proteomics Analytical Service Introduction
7.11.4 Bruker Spatial Biology Revenue in Proteomics Analytical Service Business (2021-2026)
7.11.5 Bruker Spatial Biology Recent Development
7.12 BGI Genomics
7.12.1 BGI Genomics Company Details
7.12.2 BGI Genomics Business Overview
7.12.3 BGI Genomics Proteomics Analytical Service Introduction
7.12.4 BGI Genomics Revenue in Proteomics Analytical Service Business (2021-2026)
7.12.5 BGI Genomics Recent Development
7.13 Biognosys
7.13.1 Biognosys Company Details
7.13.2 Biognosys Business Overview
7.13.3 Biognosys Proteomics Analytical Service Introduction
7.13.4 Biognosys Revenue in Proteomics Analytical Service Business (2021-2026)
7.13.5 Biognosys Recent Development
7.14 Crown Bioscience
7.14.1 Crown Bioscience Company Details
7.14.2 Crown Bioscience Business Overview
7.14.3 Crown Bioscience Proteomics Analytical Service Introduction
7.14.4 Crown Bioscience Revenue in Proteomics Analytical Service Business (2021-2026)
7.14.5 Crown Bioscience Recent Development
7.15 Eurofins Scientific
7.15.1 Eurofins Scientific Company Details
7.15.2 Eurofins Scientific Business Overview
7.15.3 Eurofins Scientific Proteomics Analytical Service Introduction
7.15.4 Eurofins Scientific Revenue in Proteomics Analytical Service Business (2021-2026)
7.15.5 Eurofins Scientific Recent Development
7.16 Charles River Laboratories
7.16.1 Charles River Laboratories Company Details
7.16.2 Charles River Laboratories Business Overview
7.16.3 Charles River Laboratories Proteomics Analytical Service Introduction
7.16.4 Charles River Laboratories Revenue in Proteomics Analytical Service Business (2021-2026)
7.16.5 Charles River Laboratories Recent Development
7.17 Discovery Life Sciences
7.17.1 Discovery Life Sciences Company Details
7.17.2 Discovery Life Sciences Business Overview
7.17.3 Discovery Life Sciences Proteomics Analytical Service Introduction
7.17.4 Discovery Life Sciences Revenue in Proteomics Analytical Service Business (2021-2026)
7.17.5 Discovery Life Sciences Recent Development
7.18 Shanghai OE Biotech
7.18.1 Shanghai OE Biotech Company Details
7.18.2 Shanghai OE Biotech Business Overview
7.18.3 Shanghai OE Biotech Proteomics Analytical Service Introduction
7.18.4 Shanghai OE Biotech Revenue in Proteomics Analytical Service Business (2021-2026)
7.18.5 Shanghai OE Biotech Recent Development
7.19 Biodesix
7.19.1 Biodesix Company Details
7.19.2 Biodesix Business Overview
7.19.3 Biodesix Proteomics Analytical Service Introduction
7.19.4 Biodesix Revenue in Proteomics Analytical Service Business (2021-2026)
7.19.5 Biodesix Recent Development
7.20 Novogene
7.20.1 Novogene Company Details
7.20.2 Novogene Business Overview
7.20.3 Novogene Proteomics Analytical Service Introduction
7.20.4 Novogene Revenue in Proteomics Analytical Service Business (2021-2026)
7.20.5 Novogene Recent Development
7.21 OmicScouts (Momentum Biotechnologies)
7.21.1 OmicScouts (Momentum Biotechnologies) Company Details
7.21.2 OmicScouts (Momentum Biotechnologies) Business Overview
7.21.3 OmicScouts (Momentum Biotechnologies) Proteomics Analytical Service Introduction
7.21.4 OmicScouts (Momentum Biotechnologies) Revenue in Proteomics Analytical Service Business (2021-2026)
7.21.5 OmicScouts (Momentum Biotechnologies) Recent Development
7.22 Lc-Bio Technologies
7.22.1 Lc-Bio Technologies Company Details
7.22.2 Lc-Bio Technologies Business Overview
7.22.3 Lc-Bio Technologies Proteomics Analytical Service Introduction
7.22.4 Lc-Bio Technologies Revenue in Proteomics Analytical Service Business (2021-2026)
7.22.5 Lc-Bio Technologies Recent Development
7.23 Creative Proteomics
7.23.1 Creative Proteomics Company Details
7.23.2 Creative Proteomics Business Overview
7.23.3 Creative Proteomics Proteomics Analytical Service Introduction
7.23.4 Creative Proteomics Revenue in Proteomics Analytical Service Business (2021-2026)
7.23.5 Creative Proteomics Recent Development
7.24 Metware Biotechnology
7.24.1 Metware Biotechnology Company Details
7.24.2 Metware Biotechnology Business Overview
7.24.3 Metware Biotechnology Proteomics Analytical Service Introduction
7.24.4 Metware Biotechnology Revenue in Proteomics Analytical Service Business (2021-2026)
7.24.5 Metware Biotechnology Recent Development
7.25 GENEWIZ (Azenta Life Sciences)
7.25.1 GENEWIZ (Azenta Life Sciences) Company Details
7.25.2 GENEWIZ (Azenta Life Sciences) Business Overview
7.25.3 GENEWIZ (Azenta Life Sciences) Proteomics Analytical Service Introduction
7.25.4 GENEWIZ (Azenta Life Sciences) Revenue in Proteomics Analytical Service Business (2021-2026)
7.25.5 GENEWIZ (Azenta Life Sciences) Recent Development
7.26 CDI Labs
7.26.1 CDI Labs Company Details
7.26.2 CDI Labs Business Overview
7.26.3 CDI Labs Proteomics Analytical Service Introduction
7.26.4 CDI Labs Revenue in Proteomics Analytical Service Business (2021-2026)
7.26.5 CDI Labs Recent Development
7.27 Evotec
7.27.1 Evotec Company Details
7.27.2 Evotec Business Overview
7.27.3 Evotec Proteomics Analytical Service Introduction
7.27.4 Evotec Revenue in Proteomics Analytical Service Business (2021-2026)
7.27.5 Evotec Recent Development
7.28 MS Bioworks
7.28.1 MS Bioworks Company Details
7.28.2 MS Bioworks Business Overview
7.28.3 MS Bioworks Proteomics Analytical Service Introduction
7.28.4 MS Bioworks Revenue in Proteomics Analytical Service Business (2021-2026)
7.28.5 MS Bioworks Recent Development
7.29 Shanghai Bioprofile
7.29.1 Shanghai Bioprofile Company Details
7.29.2 Shanghai Bioprofile Business Overview
7.29.3 Shanghai Bioprofile Proteomics Analytical Service Introduction
7.29.4 Shanghai Bioprofile Revenue in Proteomics Analytical Service Business (2021-2026)
7.29.5 Shanghai Bioprofile Recent Development
7.30 MtoZ-Biolabs
7.30.1 MtoZ-Biolabs Company Details
7.30.2 MtoZ-Biolabs Business Overview
7.30.3 MtoZ-Biolabs Proteomics Analytical Service Introduction
7.30.4 MtoZ-Biolabs Revenue in Proteomics Analytical Service Business (2021-2026)
7.30.5 MtoZ-Biolabs Recent Development
7.31 Shanghai Majorbio Bio-Pharm
7.31.1 Shanghai Majorbio Bio-Pharm Company Details
7.31.2 Shanghai Majorbio Bio-Pharm Business Overview
7.31.3 Shanghai Majorbio Bio-Pharm Proteomics Analytical Service Introduction
7.31.4 Shanghai Majorbio Bio-Pharm Revenue in Proteomics Analytical Service Business (2021-2026)
7.31.5 Shanghai Majorbio Bio-Pharm Recent Development
7.32 Firalis Molecular Precision
7.32.1 Firalis Molecular Precision Company Details
7.32.2 Firalis Molecular Precision Business Overview
7.32.3 Firalis Molecular Precision Proteomics Analytical Service Introduction
7.32.4 Firalis Molecular Precision Revenue in Proteomics Analytical Service Business (2021-2026)
7.32.5 Firalis Molecular Precision Recent Development
7.33 CD Genomics
7.33.1 CD Genomics Company Details
7.33.2 CD Genomics Business Overview
7.33.3 CD Genomics Proteomics Analytical Service Introduction
7.33.4 CD Genomics Revenue in Proteomics Analytical Service Business (2021-2026)
7.33.5 CD Genomics Recent Development
7.34 MRM Proteomics
7.34.1 MRM Proteomics Company Details
7.34.2 MRM Proteomics Business Overview
7.34.3 MRM Proteomics Proteomics Analytical Service Introduction
7.34.4 MRM Proteomics Revenue in Proteomics Analytical Service Business (2021-2026)
7.34.5 MRM Proteomics Recent Development
7.35 Panome Bio
7.35.1 Panome Bio Company Details
7.35.2 Panome Bio Business Overview
7.35.3 Panome Bio Proteomics Analytical Service Introduction
7.35.4 Panome Bio Revenue in Proteomics Analytical Service Business (2021-2026)
7.35.5 Panome Bio Recent Development
7.36 Beijing Biomarker Technologies
7.36.1 Beijing Biomarker Technologies Company Details
7.36.2 Beijing Biomarker Technologies Business Overview
7.36.3 Beijing Biomarker Technologies Proteomics Analytical Service Introduction
7.36.4 Beijing Biomarker Technologies Revenue in Proteomics Analytical Service Business (2021-2026)
7.36.5 Beijing Biomarker Technologies Recent Development
7.37 Sampled (Infinity Biologix)
7.37.1 Sampled (Infinity Biologix) Company Details
7.37.2 Sampled (Infinity Biologix) Business Overview
7.37.3 Sampled (Infinity Biologix) Proteomics Analytical Service Introduction
7.37.4 Sampled (Infinity Biologix) Revenue in Proteomics Analytical Service Business (2021-2026)
7.37.5 Sampled (Infinity Biologix) Recent Development
7.38 Sinotech Genomics
7.38.1 Sinotech Genomics Company Details
7.38.2 Sinotech Genomics Business Overview
7.38.3 Sinotech Genomics Proteomics Analytical Service Introduction
7.38.4 Sinotech Genomics Revenue in Proteomics Analytical Service Business (2021-2026)
7.38.5 Sinotech Genomics Recent Development
7.39 Applied Biomics
7.39.1 Applied Biomics Company Details
7.39.2 Applied Biomics Business Overview
7.39.3 Applied Biomics Proteomics Analytical Service Introduction
7.39.4 Applied Biomics Revenue in Proteomics Analytical Service Business (2021-2026)
7.39.5 Applied Biomics Recent Development
7.40 Westlake Omics
7.40.1 Westlake Omics Company Details
7.40.2 Westlake Omics Business Overview
7.40.3 Westlake Omics Proteomics Analytical Service Introduction
7.40.4 Westlake Omics Revenue in Proteomics Analytical Service Business (2021-2026)
7.40.5 Westlake Omics Recent Development
8 Proteomics Analytical Service Market Dynamics
8.1 Proteomics Analytical Service Industry Trends
8.2 Proteomics Analytical Service Market Drivers
8.3 Proteomics Analytical Service Market Challenges
8.4 Proteomics Analytical Service Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Proteomics Analytical Service market is projected to grow from US$ 3392 million in 2025 to US$ 6602 million by 2032, at a CAGR of 10.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-16
Pages: 202
USD 4900.00
(Single User License)
The global market for Proteomics Analytical Service was estimated to be worth US$ 3392 million in 2025 and is projected to reach US$ 6602 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published Date: 2026-07-16
Pages: 190
USD 3950.00
(Single User License)
The global Proteomics Analytical Service market was valued at US$ 3392 million in 2025 and is anticipated to reach US$ 6602 million by 2032, at a CAGR of 10.4% from 2026 to 2032.
Published Date: 2026-07-16
Pages: 206
USD 2900.00
(Single User License)
The global Proteomics Analytical Service market is projected to grow from US$ 6804 million in 2024 to US$ 15741 million by 2031, at a CAGR of 12.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-03
Pages: 155
USD 4900.00
(Single User License)
The global Proteomics Analytical Service market size was US$ 6804 million in 2024 and is forecast to a readjusted size of US$ 15741 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 101
USD 4250.00
(Single User License)
The global market for Proteomics Analytical Service was estimated to be worth US$ 6804 million in 2024 and is forecast to a readjusted size of US$ 15741 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published Date: 2025-06-05
Pages: 123
USD 3950.00
(Single User License)
The global Proteomics Analytical Service market is projected to grow from US$ 7670 million in 2025 to US$ 15741 million by 2031, at a Compound Annual Growth Rate (CAGR) of 12.7% during the forecast period.
Published Date: 2025-06-05
Pages: 154
USD 4900.00
(Single User License)
The global market for Proteomics Analytical Service was valued at US$ 6804 million in the year 2024 and is projected to reach a revised size of US$ 15741 million by 2031, growing at a CAGR of 12.7% during the forecast period.
Published Date: 2025-06-05
Pages: 94
USD 2900.00
(Single User License)
The global market for Proteomics Analytical Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-03
Pages: 159
USD 3950.00
(Single User License)
Market Analysis and Insights: Global Proteomics Analytical Service Market
Published Date: 2024-04-13
Pages: 128
USD 4900.00
(Single User License)
The global Proteomics Analytical Service market is projected to grow from US$ 3392 million in 2025 to US$ 6602 million by 2032, at a CAGR of 10.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-16
Pages: 202
The global market for Proteomics Analytical Service was estimated to be worth US$ 3392 million in 2025 and is projected to reach US$ 6602 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published: 2026-07-16
Pages: 190
The global Proteomics Analytical Service market was valued at US$ 3392 million in 2025 and is anticipated to reach US$ 6602 million by 2032, at a CAGR of 10.4% from 2026 to 2032.
Published: 2026-07-16
Pages: 206
The global Proteomics Analytical Service market is projected to grow from US$ 6804 million in 2024 to US$ 15741 million by 2031, at a CAGR of 12.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-03
Pages: 155
The global Proteomics Analytical Service market size was US$ 6804 million in 2024 and is forecast to a readjusted size of US$ 15741 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 101
The global market for Proteomics Analytical Service was estimated to be worth US$ 6804 million in 2024 and is forecast to a readjusted size of US$ 15741 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published: 2025-06-05
Pages: 123
The global Proteomics Analytical Service market is projected to grow from US$ 7670 million in 2025 to US$ 15741 million by 2031, at a Compound Annual Growth Rate (CAGR) of 12.7% during the forecast period.
Published: 2025-06-05
Pages: 154
The global market for Proteomics Analytical Service was valued at US$ 6804 million in the year 2024 and is projected to reach a revised size of US$ 15741 million by 2031, growing at a CAGR of 12.7% during the forecast period.
Published: 2025-06-05
Pages: 94
The global market for Proteomics Analytical Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 159
Market Analysis and Insights: Global Proteomics Analytical Service Market
Published: 2024-04-13
Pages: 128
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now